ArticleBMC cancer2026

TACE combined with tislelizumab and lenvatinib in the treatment of intermediate-to-advanced hepatocellular carcinoma: a retrospective real-world study.

Yanze Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.